SCHD Schwab US Dividend Equity ETF
- 81.110
- -0.500-0.61%
Kamala Harris' Potential Impact on Health Care Stocks
With President Joe Biden earlier Sunday saying he will end his campaign for re-election and endorsing Vice President Kamala Harris, the focus now turns on her positions on issues.
Here Are Big Pharma's Leading Blockbuster Makers
What to Expect in the Week Ahead (Google and Tesla Earnings; GDP and PCE Data)
This week, investors should keep an eye on earnings reports from several key players, including Google and Tesla. Key economic data to watch for will include the release of the first estimate of second-quarter gross domestic product and the Federal Reserve's preferred inflation measure for June.
How Spot Ether ETF Launch May Impact the Broader Crypto Market
Financials Dominate in Q2 as Wall Street Slides Amidst Concerns on Tech - Earnings Scorecard
Billionaire Richard Branson Once Tried Taking On Coca-Cola, Which Turned Out To Be His 'Most Notable Failure:' He Says It Taught Him That People 'Quite Like The Underdog'
Billionaire entrepreneur Richard Branson disclosed his most significant business failure- Virgin Cola– and the crucial lesson it imparted in a recent podcast. What Happened: Branson, the founder of
Unpacking the Latest Options Trading Trends in Coca-Cola
Investors with a lot of money to spend have taken a bearish stance on Coca-Cola (NYSE:KO).And retail traders should know.We noticed this today when the trades showed up on publicly available options
Catalyst Watch: Earnings Deluge, Farnborough Airshow, Paris Olympics, and Trump Talks Crypto
Chevron's Options: A Look at What the Big Money Is Thinking
Benzinga's options scanner just detected over 8 options trades for Chevron (NYSE:CVX) summing a total amount of $309,250.At the same time, our algo caught 3 for a total amount of 99,565.Projected
Peeling Back The Layers: Exploring AbbVie Through Analyst Insights
Analysts' ratings for AbbVie (NYSE:ABBV) over the last quarter vary from bullish to bearish, as provided by 10 analysts.The following table provides a quick overview of their recent ratings,
Coca-Cola Europacific Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/19/2024 12.01% Barclays $84 → $82 Maintains Overweight 07/10/2024 12.01% B of A Securities $80 → $82
BlackRock's BUIDL Tokenization Fund Hits $500M In Assets Under Management
BlackRock's(NYSE:BLK) tokenized fund BUIDL (BlackRock USD Institutional Digital Liquidity Fund) has ammassed more than $500 million in assets under management (AUM) in three months, according to a
If You Invested $100 In This Stock 15 Years Ago, You Would Have $800 Today
Texas Instruments (NASDAQ:TXN) has outperformed the market over the past 15 years by 3.05% on an annualized basis producing an average annual return of 15.2%. Currently, Texas Instruments has a
Coca-Cola FEMSA GAAP EPS of Ps. 0.33
AbbVie Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/19/2024 24.78% BMO Capital $180 → $214 Maintains Outperform 07/11/2024 14.29% Morgan Stanley $191 → $19
Dividend Roundup: Goldman Sachs, Johnson & Johnson, Qualcomm, Caterpillar, and More
Texas Instruments Declares $1.30 Dividend
Crowdstrike Global Outage Drives Rival Cybersecurity Stocks Higher
Goldman Sachs' top stock analyst: AI will not trigger an economic revolution, the bubble will burst eventually.
Jim Covello believes that the economic benefits brought by AI are not even comparable to those of smart phones and the internet; AI replaces low-paying jobs with expensive technology, which is completely opposite to the technological transformation that has occurred in the technology industry in the past thirty years.
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
GLP-1 market leaders Eli Lilly and Company (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) faced a significant selloff on Thursday, as new weight-loss drugs from rival pharmaceutical companies began threatening the dominance of their flagship products, Zepbound and Wegovy.